On Jul. 13, 2020, BioReference Laboratories, an OPKO Health company, announced that it would provide COVID-19 testing oversight for the National Basketball Association’s (NBA) players and referees, as well as team and league staff participating in the NBA’s 2020 season restart in Orlando.